tetrangomycin has been researched along with 1,2-naphthoquinone in 1 studies
| Studies (tetrangomycin) | Trials (tetrangomycin) | Recent Studies (post-2010) (tetrangomycin) | Studies (1,2-naphthoquinone) | Trials (1,2-naphthoquinone) | Recent Studies (post-2010) (1,2-naphthoquinone) |
|---|---|---|---|---|---|
| 7 | 0 | 3 | 125 | 0 | 55 |
| Protein | Taxonomy | tetrangomycin (IC50) | 1,2-naphthoquinone (IC50) |
|---|---|---|---|
| Vif | Human immunodeficiency virus 1 | 10.61 | |
| Tat | Human immunodeficiency virus 1 | 30.461 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 10.61 | |
| Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 3 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 7.1 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 1.64 | |
| Adenosine receptor A1 | Bos taurus (cattle) | 3 | |
| Genome polyprotein | Human rhinovirus sp. | 8.2 | |
| Tyrosine-protein phosphatase non-receptor type 22 | Homo sapiens (human) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barros, TF; Castilho, MS; da Silva, MVS; Emery, FS; Froes, TQ; Fumagalli, F; Mello, RB; Ribeiro, LMBC; Villamizar Gómez, SM | 1 |
1 other study(ies) available for tetrangomycin and 1,2-naphthoquinone
| Article | Year |
|---|---|
Structure-activity relationships and mechanism of action of tetragomycin derivatives as inhibitors of Staphylococcus aureus staphyloxanthin biosynthesis.
Topics: Anti-Bacterial Agents; Benz(a)Anthracenes; Drug Resistance, Multiple, Bacterial; Naphthalenes; Naphthoquinones; Staphylococcus aureus; Structure-Activity Relationship; Virulence Factors; Xanthophylls | 2020 |